Vaccination News Home Page

http://www.cnn.com/2002/HEALTH/conditions/06/06/hyper.cholera.ap/index.html

Skip to main content /HEALTH with WebMD.com
Netscape
 Free E-mail
Get Maps and Directions Free Instant Messenger Search the Internet Shop Online
CNN.com /HEALTH
CNN TV
EDITIONS




Study offers insight into cholera's virulence

June 6, 2002 Posted: 12:20 PM EDT (1620 GMT)

Save a link to this article and return to it at www.savethis.comSave a link to this article and return to it at www.savethis.com
Printer-friendly version of this articlePrinter-friendly version of this article
Email a link to this articleEmail a link to this article
View a list of the most popular articles on our siteView a list of the most popular articles on our site

(AP) -- Cholera bacteria appear to become even more infectious as they pass through the human intestinal tract, a finding that could help explain why the Third World disease spreads so quickly, researchers say.

At the same time, the finding complicates efforts to develop a vaccine, since most research uses laboratory-grown strains that are apparently less infectious than those that have gone through a person, said Andrew Camilli of the Tufts University School of Medicine.

"That's a problem. Growing bacteria up in the laboratory does not reflect what's going on in nature," said Camilli, co-author of a study in Thursday's issue of the journal Nature.

The work may help, however, in pinpointing new targets for drugs designed to fight the disease, Camilli said.

Cholera is spread by feces-contaminated water or food and each year infects as many as 300,000 people in developing countries. The disease causes severe diarrhea that can lead to extreme dehydration and death.

Before the Vibrio cholerae bacteria leave an infected person, something, perhaps stomach acid, prompts the germs to switch on a slew of genes, Camilli said. Among them are genes the bacteria need to move and to synthesize nutrients. Other genes that normally restrict the bacteria's movement are switched off, he said.

These bacteria become "hyperinfectious," or more easily capable of spreading to another person, Camilli said.

Camilli and his fellow researchers isolated cholera bacteria from the stool of patients in Bangladesh and found that the germs were 10 to 100 times more infectious than laboratory strains when injected into mice.

However, Dr. Robert Tauxe, an epidemiologist with the Centers for Disease Control and Prevention, said it is unclear whether the bacteria would be as infectious in humans as they were found to be in mice.

"The jump from saying this is infectious in mice to saying this is what causes epidemics, that's a big jump for me. It's a jump that is interesting to think about, but it's certainly not proven," Tauxe said.

Copyright 2002 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


Save a link to this article and return to it at www.savethis.comSave a link to this article and return to it at www.savethis.com  Printer-friendly version of this articlePrinter-friendly version of this article  Email a link to this articleEmail a link to this article  View a list of the most popular articles on our siteView a list of the most popular articles on our site  

  Best News Service!
  Try Money Magazine Free
  Uncut & Unedited
  French Open Coverage


Click Here to try 4 Free Trial Issues of Time!

For more Health articles, search the TIME Magazine Archive.

Click Here for 8 Free Trial issues of PEOPLE.

RELATED SITE:
Note: Pages will open in a new browser window
External sites are not endorsed by CNN Interactive.


 Search   

Back to the top

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.